Cryotherapy Versus Dexamethasone on Postoperative Pain in Permanent Mandibular Molars

NCT06832254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-03-11

No results posted yet for this study

Summary

The goal of this clinical trial was to evaluate cryotherapy versus dexamethasone on the intensity of postoperative pain in root canal treatment procedures in mandibular first molar teeth with symptomatic irreversible pulpitis. The main question it aims to answer is:

* Does controlled irrigation with cold saline in root canal treatment reduce the severity of postoperative pain?
* Does controlled irrigation with dexamethasone in root canal treatment reduce the severity of postoperative pain? In the cryotherapy group, unlike the control and dexamethasone group, the root canals were irrigated with 2 °C salin solution in final irrigation.

In the dexamethasone group, unlike the control and cryotherapy group, the root canals were irrigated with 1 mL dexamethasone solution in final irrigation.

Conditions

  • Pulpitis - Irreversible

Interventions

OTHER

Cryotherapy

The root canals were irrigated with 2 °C saline solution in final irrigation in cryotherapy group.

DRUG

Dexamethasone

Each root canal was irrigated with 1 mL dexamethasone solution in final irrigation in dexamethasone group.

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Koray Yılmaz, DDS MSc · Cukurova University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-05
Primary Completion
2024-12-10
Completion
2025-01-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06832254 on ClinicalTrials.gov